Sponsored by
AIHealthTech Insider: Issue #97
April 20, 2026
AI is already reshaping healthcare decisions, drug discovery, billing, and even what patients do instead of seeing a doctor. This issue shows the shift clearly: smarter tools are arriving fast, but access, trust, and real outcomes still decide what matters most.
Summaries are for education, not medical advice. Always verify locally before clinical use.
🔬 The Big Story
14 million Americans skipped the doctor last month — and asked AI instead
A major Gallup study released this week puts a number on something clinicians have been sensing: patients are quietly replacing visits with chatbots.
The West Health-Gallup Center surveyed over 5,500 U.S. adults and found that one in four Americans, roughly 66 million people have now used AI tools for health information or advice. Most use it to supplement care, researching before or after a doctor visit.
Image source: Gallup
But here's the finding that should keep health systems up at night:
14% of recent AI users skipped a provider visit entirely based on what the chatbot told them
Projected nationally, that's approximately 14 million adults
Only 4% strongly trust the accuracy of AI health advice
11% reported receiving AI advice they believed was unsafe
The motivations tell a deeper story. Among those who turned to AI instead of a doctor: 14% couldn't afford a visit, 16% couldn't access a provider, and 21% said they felt dismissed or ignored by a provider in the past.
Image source: ChatGPT/AIHealthTech Insider
In plain terms: millions of people are making healthcare decisions based on tools they don't fully trust not because AI is better, but because the alternative feels too expensive, too far away, or too dismissive.
Sponsored
Finally, Skincare That Boosts NAD+ At the Source
For decades, skincare has focused on aesthetic results. But we started by asking a different question: what if instead of trying to preserve our skin's youth, we prioritized optimizing our skin's function? That's how Aramore’s NAD+ skincare was born.
Developed by Harvard & MIT scientists, Aramore is a skincare system based on skin’s performance, not just its appearance. NAD+ production slows down significantly as we age, and this causes all the telltale science of aging.
Aramore is the only skincare formulated to help skin produce NAD+ like much younger skin would. The result? Skin that’s stronger, firmer, and more resilient, that not only looks better, but stays healthier over time.
⚡ Quick Hits
🔸Novo Nordisk partners with OpenAI to speed weight-loss drug discovery
On April 14, the maker of Wegovy and Ozempic announced a partnership with OpenAI to integrate AI into drug discovery and operations, aiming for full integration by late 2026. This move seeks to compete with Eli Lilly's newly approved weight-loss pill, Foundayo. OpenAI CEO Sam Altman has invested over $100 million in AI drug startups.
Image source: ChatGPT/AIHealthTech Insider
🔸First multi-agentic AI "co-scientist" for rare cancer launches commercially
Lantern Pharma launched Zeta.ai at Nasdaq MarketSite and the AACR Annual Meeting, using AI for rare cancer drug discovery. Subscriptions are open, making it one of the first commercial AI platforms for oncology R&D.
Image source: Zeta.ai
👉 Source → https://withzeta.ai/
🔸AI scribes are raising your medical bills — and everyone knows it
A Futurism investigation found that AI ambient scribes are increasing healthcare costs by documenting visits in far more detail, pushing encounters into higher billing codes. Clinicians using these tools also saw 22% more patients, boosting total billable volume. Insurers are now countering with automated downcoding.
Image source: ChatGPT/AIHealthTech Insider
👉 Source → AI Is Causing Healthcare Costs to Surge
Sponsored
Your meetings just got a lot more useful
Granola connects your meeting notes to tools like Claude and ChatGPT, so your AI actually understands your work context. Update your CRM, extract tasks, or write follow-ups without copy-pasting a thing.
🌍 Beyond AI
The type of olive oil you buy may quietly shape how your brain ages
This one isn’t about AI. But it’s too important to ignore.
A new Microbiome study in 656 older adults found a sharp split: people who used virgin olive oil preserved cognitive function over two years while those using common refined olive oil declined faster.
Image source: ChatGPT/AIHealthTech Insider
The difference wasn’t subtle.
Virgin olive oil users showed improved global and general cognition
Common olive oil users showed lower microbial diversity and accelerated decline
Every extra 10 g/day of virgin olive oil nudged cognition upward
Every extra 10 g/day of common olive oil nudged it downward
The gut seemed to be the hinge. Virgin olive oil users had a more diverse microbiome, and one genus Adlercreutzia partially mediated the cognitive benefit.
Why might this work? Virgin olive oil is rich in polyphenols that shape microbial metabolism and dampen inflammation pathways tightly linked to the gut–brain axis.
It’s early, and this isn’t a randomized trial. But the idea that the difference between “virgin” and “refined” on a label could influence how your brain ages is exactly the kind of finding nutrition scientists don’t ignore.
Sponsored
The World's Biggest Dev Event Hits Silicon Valley
From AI and cloud to DevOps and security — WeAreDevelopers World Congress brings the entire modern stack to San Jose. 500+ speakers. 10,000+ developers. One epic September. Use code GITPUSH26 for 10% off.
💡 The One Thing
The real issue is not AI replacing doctors, but 14 million people turning to chatbots due to expensive, inaccessible, or inattentive healthcare. AI tools are increasing costs, revealing a gap between patient needs and system delivery. Until this gap closes, people will seek any available help.
Image source: ChatGPT/AIHealthTech Insider
Would you use AI health advice if you couldn't afford a doctor?
Stay ahead: AI Healthcare News!
This is just a glimpse of the AI healthcare revolution. Subscribe for exclusive updates on medicine’s future!
